October 2024

A New Brain Neuromodulation Therapy Sparks High Interest from Major Pharma Executives  TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ — Neurolief, a leading pioneer in neuromodulation technology, recently unveiled its pivotal multicenter RCT clinical study results for its Proliv™Rx brain neuromodu

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: